Mechanism of lovastatin in promoting ferroptosis of prostate cancer cells by regulating the mevalonate pathway.

Xiao Y, Liu Z, Feng Y, Zhu H, Wang B, Chen S, Liang G

Open source

DOI
10.4081/ejh.2026.4575
Published
2026 Jul 23
Container
European journal of histochemistry : EJH
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.4081/ejh.2026.4575,
  title = {Mechanism of lovastatin in promoting ferroptosis of prostate cancer cells by regulating the mevalonate pathway.},
  author = {Xiao Y and Liu Z and Feng Y and Zhu H and Wang B and Chen S and Liang G},
  year = {2026},
  journal = {European journal of histochemistry : EJH},
  doi = {10.4081/ejh.2026.4575},
  url = {https://doi.org/10.4081/ejh.2026.4575}
}

RIS

TY  - JOUR
TI  - Mechanism of lovastatin in promoting ferroptosis of prostate cancer cells by regulating the mevalonate pathway.
AU  - Xiao Y
AU  - Liu Z
AU  - Feng Y
AU  - Zhu H
AU  - Wang B
AU  - Chen S
AU  - Liang G
PY  - 2026
JO  - European journal of histochemistry : EJH
DO  - 10.4081/ejh.2026.4575
UR  - https://doi.org/10.4081/ejh.2026.4575
ER  - 

APA

Y, X., Z, L., Y, F., H, Z., B, W., S, C., & G, L. (2026). Mechanism of lovastatin in promoting ferroptosis of prostate cancer cells by regulating the mevalonate pathway.. European journal of histochemistry : EJH. https://doi.org/10.4081/ejh.2026.4575

Source records